Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
Browse the full article libraryMoving from the oral tablet to the weekly injection usually means more weight loss and no more fasted-dosing ritual — a common upgrade.
Often a cost or supply decision. Since both are semaglutide, your dose carries over directly with no re-titration needed.
Same molecule, so the switch is smooth — Wegovy simply allows a higher weight-loss dose (up to 2.4 mg) under its weight-management label.
People switch this way usually for cost or availability. Expect a small step back in average weight loss, but semaglutide remains highly effective.
Switching from semaglutide to tirzepatide can break a weight-loss plateau and often increases total weight loss, thanks to Mounjaro's dual hormone action.
Two very different paths. GLP-1 delivers ~15–20% weight loss medically; bariatric surgery delivers ~25–35% but is a permanent operation.
Two very different paths. GLP-1 delivers ~15–20% weight loss medically; bariatric surgery delivers ~25–35% but is a permanent operation.
Two very different paths. GLP-1 delivers ~15–20% weight loss medically; bariatric surgery delivers ~25–35% but is a permanent operation.
Two very different paths. GLP-1 delivers ~15–20% weight loss medically; bariatric surgery delivers ~25–35% but is a permanent operation.
Two very different paths. GLP-1 delivers ~15–20% weight loss medically; bariatric surgery delivers ~25–35% but is a permanent operation.
Both weekly injections for diabetes, but semaglutide (Ozempic) generally lowers sugar and weight more than dulaglutide (Trulicity).
Both weekly injections for diabetes, but semaglutide (Ozempic) generally lowers sugar and weight more than dulaglutide (Trulicity).
